Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice
- PMID: 18997037
- DOI: 10.2967/jnumed.108.053215
Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice
Abstract
3'-Deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) is a thymidine analog that was developed for measuring tumor proliferation with PET. The aim of this study was to establish a kinetic modeling analysis method for quantitative (18)F-FLT PET studies in subcutaneous tumor models in mice.
Methods: To explore the validity of an image-derived left ventricular input function, we measured equilibrium constants for plasma and whole blood and metabolite fractions in blood after (18)F-FLT injection. In parallel, dynamic (18)F-FLT PET scans were acquired in 24 mice with a small-animal dedicated PET scanner to compare arterial blood activities obtained by PET and blood sampling. We then investigated kinetic models for (18)F-FLT in human epithelial carcinoma (A431) and Lewis lung carcinoma tumor models in mice. Three-compartment models with reversible phosphorylation (k(4) not equal 0, 3C5P) and irreversible phosphorylation (k(4) = 0, 3C4P) and a 2-compartment model (2C3P) were examined. The Akaike information criterion and F statistics were used to select the best model for the dataset. Gjedde-Patlak graphic analysis was performed, and standardized uptake values in the last frame were calculated for comparison purposes. In addition, quantitative PET parameters were compared with Ki-67 immunostaining results.
Results: (18)F-FLT equilibrated rapidly (within 30 s) between plasma and whole blood, and metabolite fractions were negligible during PET scans. A high correlation between arterial blood sampling and PET data was observed. For 120-min dynamic PET data, the 3C5P model best described tissue time-activity curves for tumor regions. The net influx of (18)F-FLT (K(FLT)) and k(3) obtained with this model showed reasonable intersubject variability and discrimination ability for tumor models with different proliferation properties. The K(FLT) obtained from the 60- or 90-min data correlated well with that obtained from the 120-min data as well as with the Ki-67 results.
Conclusion: The image-derived arterial input function was found to be feasible for kinetic modeling studies of (18)F-FLT PET in mice, and kinetic modeling analysis with an adequate compartment model provided reliable kinetic parameters for measuring tumor proliferation.
Similar articles
-
Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.J Nucl Med. 2005 Feb;46(2):274-82. J Nucl Med. 2005. PMID: 15695787 Clinical Trial.
-
Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.J Nucl Med. 2005 Feb;46(2):371-80. J Nucl Med. 2005. PMID: 15695799
-
Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy.J Nucl Med. 2009 Jul;50(7):1028-35. doi: 10.2967/jnumed.108.058495. Epub 2009 Jun 12. J Nucl Med. 2009. PMID: 19525472 Free PMC article. Clinical Trial.
-
Applications of PET imaging with the proliferation marker [18F]-FLT.Q J Nucl Med Mol Imaging. 2015 Mar;59(1):95-104. Epub 2015 Mar 4. Q J Nucl Med Mol Imaging. 2015. PMID: 25737423 Free PMC article. Review.
-
PET imaging of proliferation with pyrimidines.J Nucl Med. 2013 Jun;54(6):903-12. doi: 10.2967/jnumed.112.112201. Epub 2013 May 14. J Nucl Med. 2013. PMID: 23674576 Review.
Cited by
-
Evaluation of [18F]Fluorothymidine as a Biomarker for Early Therapy Response in a Mouse Model of Colorectal Cancer.Mol Imaging Biol. 2017 Feb;19(1):109-119. doi: 10.1007/s11307-016-0974-5. Mol Imaging Biol. 2017. PMID: 27324368
-
Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism.J Nucl Med. 2021 Aug 1;62(8):1154-1162. doi: 10.2967/jnumed.120.250977. Epub 2020 Dec 4. J Nucl Med. 2021. PMID: 33277391 Free PMC article.
-
Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1859-68. doi: 10.1007/s00259-015-3085-7. Epub 2015 May 28. Eur J Nucl Med Mol Imaging. 2015. PMID: 26016906 Free PMC article.
-
Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with (99m)Tc- and (123)I-labelled probes.Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1495-509. doi: 10.1007/s00259-009-1142-9. Epub 2009 May 7. Eur J Nucl Med Mol Imaging. 2009. PMID: 19421750 Free PMC article.
-
PET/CT imaging in mouse models of myocardial ischemia.J Biomed Biotechnol. 2012;2012:541872. doi: 10.1155/2012/541872. Epub 2012 Mar 13. J Biomed Biotechnol. 2012. PMID: 22505813 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical